Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Shareholders' Equity

v3.25.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Ordinary Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 421 $ 7,611,564 $ (477,079) $ (7,066,315) $ 68,591
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation   118,940     118,940
Issuance of shares under employee related plans 4 5,303     5,307
Common share issuance for NCLC exchangeable notes   10     10
Net share settlement of restricted share units   (26,860)     (26,860)
Other comprehensive income (loss), net     (31,359)   (31,359)
Net income       166,178 166,178
Balance at Dec. 31, 2023 425 7,708,957 (508,438) (6,900,137) 300,807
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation   91,781     91,781
Issuance of shares under employee related plans 4 (4)      
Common share issuance for NCLC exchangeable notes 11 146,517     146,528
Net share settlement of restricted share units   (25,333)     (25,333)
Other comprehensive income (loss), net     1,399   1,399
Net income       910,257 910,257
Balance at Dec. 31, 2024 440 7,921,918 (507,039) (5,989,880) 1,425,439
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation   88,393     88,393
Issuance of shares under employee related plans 3 (3)      
Common share issuance proceeds, net 7 144,949     144,956
Common share issuance for NCLC exchangeable notes 5 96,001     96,006
Net share settlement of restricted share units   (23,826)     (23,826)
Other comprehensive income (loss), net     55,674   55,674
Net income       423,246 423,246
Balance at Dec. 31, 2025 $ 455 $ 8,227,432 $ (451,365) $ (5,566,634) $ 2,209,888